Trial Profile
Open label, flexible dose 12-week clinical trial of the safety and efficacy of acamprosate in the treatment of pathological gambling
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Acamprosate (Primary)
- Indications Gambling
- Focus Therapeutic Use
- 07 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Dec 2007 New trial record.